drugset / Trial / NCT00544986

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

NCT00544986

Phase 4 Completed AstraZeneca
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The overall objective of the clinical study is to assess the tolerability and clinical efficacy of anastrozole in post-menopausal women with hormone sensitive advanced breast cancer in India.

Timeline

Start
2005-06
Primary completion
2007-11
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Anastrozole Other / unclassified

Indications